Last Action:
05/12/2025 H Laid on the table subject to call
Council Document:
89R 14527 CJD-F
Caption Version:
House Committee Report
Caption Text:
Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.
Author:
Harris | Leach | Phelan | Orr | VanDeaver
Coauthor:
Alders | Barry | Bell, Keith | Buckley | Cain | Davis, Aicha | Gámez | Garcia, Josey | Gerdes | Hefner | LaHood | Lalani | Leo Wilson | Lopez, Janie | Lujan | McLaughlin | Metcalf | Morales Shaw | Morales, Eddie | Olcott | Pierson | Raymond | Schoolcraft | Shofner | Swanson | Tinderholt | Vasut | Villalobos | Zwiener
Subjects:
Alcoholism & Drug Abuse (I0030)
Crimes--Drugs (I0185)
Health--General (I0385)
State Finances--Appropriations (I0746)
MEDICINE & PRESCRIPTION DRUGS (S7338)
RESEARCH & DEVELOPMENT (S0135)
HEALTH & HUMAN SERVICES COMMISSION (V0177)
Companion:
House Committee:
House Committee Status:
Out of committee
House Committee Vote:
Ayes=13 Nays=0 Present Not Voting=0 Absent=0